Ziad W. Elmezayen
Ziad W. Elmezayen has a total of 49 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Adi
Damascus University
6 shared publications Ahmed Wahba
2 shared publications- Hossam Salameh
Department of Medicine An‐Najah National University Nablus Palestine
2 shared publications - Nasim Abukaresh
Palestine Polytechnic University
2 shared publications - Sameh M. Said
Division of Pediatric and Adult Congenital Cardiac Surgery, Maria Fareri Children’s Hospital, Department of Surgery, Westchester Medical Center, New York, NY 10595, USA
2 shared publications Zeina Zakarya Marzouk
Department of Dermatology, National Hospital, Latakia, Syria
2 shared publications
Latest Publications
- Open Access
- 23 October 2026
- Published by Elsevier in JTCVS Open
Rethinking Off-Pump Extracardiac Fontan Completion: A Systematic Review and Meta-Analysis of Over 500 Cases
- 23 October 2026
- Published by Elsevier in JTCVS Open
Open AccessRethinking Off-Pump Extracardiac Fontan Completion: A Systematic Review and Meta-Analysis of Over 500 Cases
- Open Access
- 18 June 2026
- Published by Elsevier in JTCVS Techniques
- Vol. 39, 102490
Complete Dacron reinforcement of Ross autograft does not increase neoaortic valve regurgitation: A systematic review and meta-analysis
- 18 June 2026
- Published by Elsevier in JTCVS Techniques
- Vol. 39, 102490
Open AccessComplete Dacron reinforcement of Ross autograft does not increase neoaortic valve regurgitation: A systematic review and meta-analysis
- Open Access
- 8 June 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (6) , omag099
A rare case of pregnancy-associated thrombotic thrombocytopenic purpura
Thrombotic Thrombocytopenic Purpura (TTP) is a rare but potentially life-threatening thrombotic microangiopathy that presents significant diagnostic and therapeutic difficulties during pregnancy due to overlap with conditions like HELLP syndrome and preeclampsia. We present the case of a previously healthy 28-year-old woman at 34 weeks of gestation presenting with fatigue, headache, and petechiae. Laboratory tests indicated anemia, thrombocytopenia, increased lactate dehydrogenase levels, and the presence of schistocytes in the peripheral smear. Low ADAMTS13 activity (<10%) confirmed TTP. The patient showed significant improvement after receiving corticosteroids and undergoing daily plasma exchange. For maternal stability, an elective caesarean section was performed at 36 weeks, resulting in good maternal and neonatal outcomes. Early detection requires the timely diagnosis of unexplained thrombocytopenia, hemolysis, and neurologic symptoms in the absence of hypertension or abnormal coagulation, which should prompt immediate ADAMTS13 testing. Diagnosis and treatment were guided by multidisciplinary management and ADAMTS13 testing, resulting in complete remission without relapsing at the six-week follow-up.
- 8 June 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (6) , omag099
Open AccessA rare case of pregnancy-associated thrombotic thrombocytopenic purpura
Thrombotic Thrombocytopenic Purpura (TTP) is a rare but potentially life-threatening thrombotic microangiopathy that presents significant diagnostic and therapeutic difficulties during pregnancy due to overlap with conditions like HELLP syndrome and preeclampsia. We present the case of a previously healthy 28-year-old woman at 34 weeks of gestation presenting with fatigue, headache, and petechiae. Laboratory tests indicated anemia, thrombocytopenia, increased lactate dehydrogenase levels, and the presence of schistocytes in the peripheral smear. Low ADAMTS13 activity (<10%) confirmed TTP. The patient showed significant improvement after receiving corticosteroids and undergoing daily plasma exchange. For maternal stability, an elective caesarean section was performed at 36 weeks, resulting in good maternal and neonatal outcomes. Early detection requires the timely diagnosis of unexplained thrombocytopenia, hemolysis, and neurologic symptoms in the absence of hypertension or abnormal coagulation, which should prompt immediate ADAMTS13 testing. Diagnosis and treatment were guided by multidisciplinary management and ADAMTS13 testing, resulting in complete remission without relapsing at the six-week follow-up.
- Open Access
- 22 April 2026
- Published by SAGE Publications in Clinical Medicine Insights: Endocrinology and Diabetes
- Vol. 19
Euthyroid Sick Syndrome Precipitated By Rapid Weight Loss Following Semaglutide Initiation: A Case Report
Euthyroid sick syndrome (ESS) is characterized by abnormal thyroid function tests, most notably a low triiodothyronine (T3) level, occurring in the absence of intrinsic thyroid disease. A 54-year-old woman presented to the endocrinology clinic with a 4-month history of progressive fatigue, lethargy, and new-onset cold intolerance after initiation of semaglutide for weight management. The dose was titrated monthly over 4 months, during which she experienced significant weight loss of 22 kg. Laboratory evaluation revealed a thyroid function profile classic for ESS, with low free T3, low-normal free T4, and a normal thyroid-stimulating hormone (TSH) level that was inappropriately low relative to the reduced T3. After exclusion of primary thyroid and pituitary disorders, a diagnosis of ESS secondary to the catabolic state induced by rapid weight loss was made. The patient was counseled that this represented a physiological adaptation rather than intrinsic thyroid disease. Semaglutide was continued given its metabolic benefits, and nutritional optimization with adequate caloric and protein intake was advised.
- 22 April 2026
- Published by SAGE Publications in Clinical Medicine Insights: Endocrinology and Diabetes
- Vol. 19
Open AccessEuthyroid Sick Syndrome Precipitated By Rapid Weight Loss Following Semaglutide Initiation: A Case Report
Euthyroid sick syndrome (ESS) is characterized by abnormal thyroid function tests, most notably a low triiodothyronine (T3) level, occurring in the absence of intrinsic thyroid disease. A 54-year-old woman presented to the endocrinology clinic with a 4-month history of progressive fatigue, lethargy, and new-onset cold intolerance after initiation of semaglutide for weight management. The dose was titrated monthly over 4 months, during which she experienced significant weight loss of 22 kg. Laboratory evaluation revealed a thyroid function profile classic for ESS, with low free T3, low-normal free T4, and a normal thyroid-stimulating hormone (TSH) level that was inappropriately low relative to the reduced T3. After exclusion of primary thyroid and pituitary disorders, a diagnosis of ESS secondary to the catabolic state induced by rapid weight loss was made. The patient was counseled that this represented a physiological adaptation rather than intrinsic thyroid disease. Semaglutide was continued given its metabolic benefits, and nutritional optimization with adequate caloric and protein intake was advised.
- Open Access
- 21 April 2026
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 19
Sydenham’s Chorea as the Sole Presenting Symptom of Acute Rheumatic Fever in a 14-Year-Old Boy: A Case Report
Background: Rheumatic chorea is an uncommon but time-honored neurological manifestation of acute rheumatic fever that usually presents weeks to months after an untreated streptococcal pharyngitis. When it presents alone, that is, without other manifestations of the disease, it could easily be overlooked or delayed in its diagnosis. In such a scenario, it is uniquely presented as an isolated primary presentation of rheumatic fever, which underscores the challenge of diagnosis and the importance of early recognition. Case presentation: A 14-year-old boy presented with automatic, aimless, and arrhythmic movements of his limbs and face. There was no fever, rash, or joint pain in the preceding weeks. Neurological examination demonstrated choreiform movements typical of Sydenham’s chorea, and serology suggested a recent Group A streptococcal infection. Transthoracic echocardiography revealed mild mitral valve leaflet thickening with mild mitral regurgitation consistent with subclinical rheumatic carditis. The patient was treated with benzathine penicillin for eradication and long-term prophylaxis, and valproic acid for symptomatic control. Symptoms improved over weeks and follow-up assessments showed near resolution of valvular changes without development of clinically significant rheumatic heart disease. Conclusion: This case highlights that rheumatic chorea may occur as an isolated type of acute rheumatic fever. Recognition of such a presentation is important in making early diagnosis and treatment, which are essential to prevent long-term effects such as rheumatic heart disease.
- 21 April 2026
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 19
Open AccessSydenham’s Chorea as the Sole Presenting Symptom of Acute Rheumatic Fever in a 14-Year-Old Boy: A Case Report
Background: Rheumatic chorea is an uncommon but time-honored neurological manifestation of acute rheumatic fever that usually presents weeks to months after an untreated streptococcal pharyngitis. When it presents alone, that is, without other manifestations of the disease, it could easily be overlooked or delayed in its diagnosis. In such a scenario, it is uniquely presented as an isolated primary presentation of rheumatic fever, which underscores the challenge of diagnosis and the importance of early recognition. Case presentation: A 14-year-old boy presented with automatic, aimless, and arrhythmic movements of his limbs and face. There was no fever, rash, or joint pain in the preceding weeks. Neurological examination demonstrated choreiform movements typical of Sydenham’s chorea, and serology suggested a recent Group A streptococcal infection. Transthoracic echocardiography revealed mild mitral valve leaflet thickening with mild mitral regurgitation consistent with subclinical rheumatic carditis. The patient was treated with benzathine penicillin for eradication and long-term prophylaxis, and valproic acid for symptomatic control. Symptoms improved over weeks and follow-up assessments showed near resolution of valvular changes without development of clinically significant rheumatic heart disease. Conclusion: This case highlights that rheumatic chorea may occur as an isolated type of acute rheumatic fever. Recognition of such a presentation is important in making early diagnosis and treatment, which are essential to prevent long-term effects such as rheumatic heart disease.
- Open Access
- 21 April 2026
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 19
Systemic Epinephrine Toxicity Following Topical Anesthetic Gel on Mucosal Surfaces: A Case Report and Literature Review
Introduction: Systemic toxicity from topical epinephrine is rare because dermal and mucosal absorption is typically limited. However, application to highly vascular mucosa, particularly under occlusion, may result in clinically significant systemic absorption. Case presentation: A 42-year-old woman developed severe headache, palpitations, tremor, and marked hypertension shortly after a compounded 2.5% lidocaine with epinephrine (1:2000; 0.5 mg/mL) gel was applied to the labial mucosa under occlusion during a cosmetic procedure. An estimated 0.5 to 1.5 mg of epinephrine was applied. Symptoms began within 10 minutes and persisted until gel removal approximately 25 minutes later. On EMS arrival, heart rate was 145 bpm and blood pressure 210/110 mmHg. In the emergency department, ECG showed sinus tachycardia without ischemic changes; laboratory studies were unremarkable except for mild respiratory alkalosis, and serial high-sensitivity troponin I was negative. Management included prompt removal of the topical agent, supportive care, and cardiac monitoring. Symptoms resolved spontaneously without pharmacologic intervention, and the patient was discharged after 4 hours of observation. Conclusion: Topical epinephrine applied to highly vascular mucosal surfaces—especially under occlusion—can rarely cause systemic sympathomimetic toxicity characterized by hypertension, tachycardia, tremor, and anxiety. Although it may resemble local anesthetic systemic toxicity, it is clinically distinct. Careful dosing, avoidance of occlusive dressings, close monitoring, and immediate removal of the agent at the first sign of systemic effects are essential to prevent complications.
- 21 April 2026
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 19
Open AccessSystemic Epinephrine Toxicity Following Topical Anesthetic Gel on Mucosal Surfaces: A Case Report and Literature Review
Introduction: Systemic toxicity from topical epinephrine is rare because dermal and mucosal absorption is typically limited. However, application to highly vascular mucosa, particularly under occlusion, may result in clinically significant systemic absorption. Case presentation: A 42-year-old woman developed severe headache, palpitations, tremor, and marked hypertension shortly after a compounded 2.5% lidocaine with epinephrine (1:2000; 0.5 mg/mL) gel was applied to the labial mucosa under occlusion during a cosmetic procedure. An estimated 0.5 to 1.5 mg of epinephrine was applied. Symptoms began within 10 minutes and persisted until gel removal approximately 25 minutes later. On EMS arrival, heart rate was 145 bpm and blood pressure 210/110 mmHg. In the emergency department, ECG showed sinus tachycardia without ischemic changes; laboratory studies were unremarkable except for mild respiratory alkalosis, and serial high-sensitivity troponin I was negative. Management included prompt removal of the topical agent, supportive care, and cardiac monitoring. Symptoms resolved spontaneously without pharmacologic intervention, and the patient was discharged after 4 hours of observation. Conclusion: Topical epinephrine applied to highly vascular mucosal surfaces—especially under occlusion—can rarely cause systemic sympathomimetic toxicity characterized by hypertension, tachycardia, tremor, and anxiety. Although it may resemble local anesthetic systemic toxicity, it is clinically distinct. Careful dosing, avoidance of occlusive dressings, close monitoring, and immediate removal of the agent at the first sign of systemic effects are essential to prevent complications.
- Open Access
- 7 April 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Fulminant campylobacter jejuni bacteremia complicating steroid-dependent nephrotic syndrome in a pediatric patient: a case report
Background: Campylobacter jejuni (C. jejuni) usually causes mild diarrhea but can rarely enter the bloodstream and cause severe infection. Children with nephrotic syndrome (NS) are more likely to get serious infections because of immune weakness from protein loss and steroid use. Case presentation: A 7-year-old boy with steroid-dependent NS came to the hospital with fever, diarrhea, and abdominal pain. He quickly developed septic shock and was treated in the intensive care unit. jejuni was isolated from the blood culture, which was resistant to fluoroquinolones but sensitive to macrolides. After switching to azithromycin and adjusting his steroid therapy, the patient showed rapid improvement and made a full recovery. Conclusion: This case shows that C. jejuni can cause dangerous infections in children with NS. Clinicians should keep C. jejuni in mind when treating nephrotic children with sepsis and diarrhea, ensuring timely culture testing and targeted antibiotic treatment to avoid severe outcomes. Clinical trial number: Not applicable.
- 7 April 2026
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 26 (1)
Open AccessFulminant campylobacter jejuni bacteremia complicating steroid-dependent nephrotic syndrome in a pediatric patient: a case report
Background: Campylobacter jejuni (C. jejuni) usually causes mild diarrhea but can rarely enter the bloodstream and cause severe infection. Children with nephrotic syndrome (NS) are more likely to get serious infections because of immune weakness from protein loss and steroid use. Case presentation: A 7-year-old boy with steroid-dependent NS came to the hospital with fever, diarrhea, and abdominal pain. He quickly developed septic shock and was treated in the intensive care unit. jejuni was isolated from the blood culture, which was resistant to fluoroquinolones but sensitive to macrolides. After switching to azithromycin and adjusting his steroid therapy, the patient showed rapid improvement and made a full recovery. Conclusion: This case shows that C. jejuni can cause dangerous infections in children with NS. Clinicians should keep C. jejuni in mind when treating nephrotic children with sepsis and diarrhea, ensuring timely culture testing and targeted antibiotic treatment to avoid severe outcomes. Clinical trial number: Not applicable.
- Open Access
- 18 March 2026
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 19
Severe Intravascular Hemolysis and Acute Kidney Injury Triggered by Mycoplasma-Associated Cold Agglutinin Disease: A Case Report
Introduction: Mycoplasma pneumoniae infection commonly causes mild respiratory illness, but cold agglutinin syndrome (CAS) is an uncommon extrapulmonary complication. CAS typically results in mild, predominantly extravascular hemolysis; however, severe intravascular hemolysis and acute kidney injury (AKI) are rare. Case presentation: A 59-year-old woman presented with profound weakness, jaundice, dark urine, and anuria following a mild upper respiratory illness. Laboratory evaluation revealed severe intravascular hemolysis, markedly elevated LDH activity, undetectable hemoglobin (Hb) level, hemoglobinuria, and AKI. Direct antiglobulin testing was positive for C3d only, and the cold agglutinin titer was markedly elevated (1:2048). Mycoplasma pneumoniae IgM serology was positive. She required warmed blood transfusions, antibiotics, thermal protection, and continuous renal replacement therapy. Over 10 days, hemolysis-related laboratory parameters and serum creatinine level improved significantly. Conclusion: This case illustrates a rare and severe form of Mycoplasma pneumoniae-associated CAS presenting with massive intravascular hemolysis and AKI. Early recognition and supportive interventions—particularly warmed transfusions and renal support—were critical to recovery. Clinicians should consider cold agglutinin-mediated hemolysis in patients with dark urine and AKI following respiratory infection.
- 18 March 2026
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 19
Open AccessSevere Intravascular Hemolysis and Acute Kidney Injury Triggered by Mycoplasma-Associated Cold Agglutinin Disease: A Case Report
Introduction: Mycoplasma pneumoniae infection commonly causes mild respiratory illness, but cold agglutinin syndrome (CAS) is an uncommon extrapulmonary complication. CAS typically results in mild, predominantly extravascular hemolysis; however, severe intravascular hemolysis and acute kidney injury (AKI) are rare. Case presentation: A 59-year-old woman presented with profound weakness, jaundice, dark urine, and anuria following a mild upper respiratory illness. Laboratory evaluation revealed severe intravascular hemolysis, markedly elevated LDH activity, undetectable hemoglobin (Hb) level, hemoglobinuria, and AKI. Direct antiglobulin testing was positive for C3d only, and the cold agglutinin titer was markedly elevated (1:2048). Mycoplasma pneumoniae IgM serology was positive. She required warmed blood transfusions, antibiotics, thermal protection, and continuous renal replacement therapy. Over 10 days, hemolysis-related laboratory parameters and serum creatinine level improved significantly. Conclusion: This case illustrates a rare and severe form of Mycoplasma pneumoniae-associated CAS presenting with massive intravascular hemolysis and AKI. Early recognition and supportive interventions—particularly warmed transfusions and renal support—were critical to recovery. Clinicians should consider cold agglutinin-mediated hemolysis in patients with dark urine and AKI following respiratory infection.
- Open Access
- 18 March 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Severe, late-onset neutropenia associated with prolonged furosemide administration in an extremely preterm infant: a case report and literature review
Furosemide is commonly used off-label in the neonatal intensive care unit to promote diuresis and improve pulmonary mechanics in preterm infants, but prolo
- 18 March 2026
- Published by Springer Nature in BMC Pediatrics
- Vol. 26 (1)
Open AccessSevere, late-onset neutropenia associated with prolonged furosemide administration in an extremely preterm infant: a case report and literature review
Furosemide is commonly used off-label in the neonatal intensive care unit to promote diuresis and improve pulmonary mechanics in preterm infants, but prolo
- Open Access
- 17 March 2026
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 19
A Case of Prolonged Atelectasis and Recurrent Pneumonia Secondary to an Unsuspected Chicken Bone Aspiration: A Case Report
Background: Foreign body aspiration (FBA) in adults is rare and often overlooked, presenting with nonspecific pulmonary symptoms that may mimic recurrent infections or malignancy. Delay in diagnosis can lead to prolonged morbidity and mismanagement. Case Presentation: We report a 55-year-old woman with a 2-month history of productive cough, intermittent hemoptysis, dyspnea, pleuritic chest pain, and recurrent pneumonia unresponsive to multiple courses of antibiotics and corticosteroids. Chest X-ray revealed right middle-lobe collapse, while computed tomography demonstrated a linear radiopaque lesion in the right middle-lobe bronchus. Flexible bronchoscopy confirmed complete bronchial obstruction by purulent debris concealing a sharp chicken bone fragment, which was retrieved successfully. The patient showed rapid clinical improvement following removal. Conclusion: This case underscores the importance of considering FBA in the differential diagnosis of persistent atelectasis or treatment-resistant pneumonia in adults, even in the absence of aspiration history or risk factors. Diagnostic bronchoscopy remains the gold standard, enabling both definitive diagnosis and therapeutic intervention, thereby preventing misdiagnosis as neoplasm and avoiding unnecessary procedures.
- 17 March 2026
- Published by SAGE Publications in Clinical Medicine Insights: Case Reports
- Vol. 19
Open AccessA Case of Prolonged Atelectasis and Recurrent Pneumonia Secondary to an Unsuspected Chicken Bone Aspiration: A Case Report
Background: Foreign body aspiration (FBA) in adults is rare and often overlooked, presenting with nonspecific pulmonary symptoms that may mimic recurrent infections or malignancy. Delay in diagnosis can lead to prolonged morbidity and mismanagement. Case Presentation: We report a 55-year-old woman with a 2-month history of productive cough, intermittent hemoptysis, dyspnea, pleuritic chest pain, and recurrent pneumonia unresponsive to multiple courses of antibiotics and corticosteroids. Chest X-ray revealed right middle-lobe collapse, while computed tomography demonstrated a linear radiopaque lesion in the right middle-lobe bronchus. Flexible bronchoscopy confirmed complete bronchial obstruction by purulent debris concealing a sharp chicken bone fragment, which was retrieved successfully. The patient showed rapid clinical improvement following removal. Conclusion: This case underscores the importance of considering FBA in the differential diagnosis of persistent atelectasis or treatment-resistant pneumonia in adults, even in the absence of aspiration history or risk factors. Diagnostic bronchoscopy remains the gold standard, enabling both definitive diagnosis and therapeutic intervention, thereby preventing misdiagnosis as neoplasm and avoiding unnecessary procedures.